Displaying items by tag: research
A new study confirms that G207, a genetically engineered virus developed at UAB, may be a beneficial therapy for brain tumors.
Disruption of Blimp1 in regulatory T cells remodels the tumor microenvironment and augments the response to immunotherapy.
At UAB, the company IN8bio Inc. is running a Phase I clinical trial to treat glioblastoma multiforme, the most aggressive type of cancer that originates in the brain.
The PPMI study is looking for biomarkers for Parkinson’s disease, which would help identify those at risk and track the progression of the disease.
Recent studies have shown that formal exercise training can help boost memory, and memory deficit is relatively common in people with epilepsy.
Basic and translational research in this field aims to repair heart injury and prevent the heart failure that often follows a heart attack.
The largest registry of U.S. children with cancer who were diagnosed with COVID-19 found an increased risk of having severe infection and having their cancer therapy modified because of COVID, underscoring the urgency of vaccinations for these children, the authors say.
The Hugh Kaul Precision Medicine Institute will help build the interface of the Biomedical Data Translator, a “virtual brain” that will host all biomedical data in the world.
The 10-week trial will include meals provided by study investigators.
Young cancer survivors are at higher risk of developing subsequent HPV-related cancers than the general population, but less likely to receive the HPV vaccine. Findings from the first clinical trial of its kind support making HPV vaccination a routine part of oncologic care for all young cancer survivors, researchers say.
